Results:
Keyword: album OR release OR Community OR Science OR Reporting OR award

Dec. 5, 2017

Project Announcement: Audit of the DoD One Acquisition Solution for Integrated Services Contracts (Project No. D2018-D000AT-0062.000)

We plan to begin the subject audit in December 2017. Our objective is to determine whether the DoD was properly charged for the One Acquisition Solution for Integrated Services contracts. This is report DoD Task Orders Issued Under One Acquisition Solution for Integrated Services Contracts DODIG-2019-029.

Dec. 1, 2017

Semiannual Report to the Congress: April 1, 2017 through September 30, 2017

This report summarizes the work of the Department of Defense (DoD) Office of Inspector General (OIG) from April 1, 2017, through September 30, 2017. It identifies oversight conducted by the OIG during the past 6 months, which demonstrates the importance of our efforts to detect and deter fraud, waste, and abuse in DoD programs and operations; to seek to improve the economy, efficiency, and effectiveness of DoD programs; and to help ensure ethical conduct throughout the DoD.

Dec. 1, 2017

Evaluation of the Long Range Strike-Bomber Program Security Controls (Classified) DODIG-2018-037

This report is classified. To view a redacted copy in the FOIA Reading Room click here This report is a result of Project No. D2017-DISPA3-0050.000.

Dec. 1, 2017

Project Announcement: Audit of the DoD Agency-Wide Basic Financial Statements for Fiscal Years Ending September 30, 2018, and September 30, 2017 (Project No. D2018-D000FE-0063.000)

We plan to begin the subject audit in December 2017. The Chief Financial Officers Act of 1990, as amended, requires this audit. In accordance with the Chief Financial Officers Act of 1990, the DoD Office of Inspector General is the principal auditor for the DoD Agency-Wide Basic Financial Statements. Our objective is to determine whether the DoD Agency-Wide Basic Financial Statements as of September 30, 2018, and September 30, 2017, taken as a whole, were presented fairly, in all material respects, and in conformity with accounting principles generally accepted in the United States of America. This is report Independent Auditor's Report on the Department of Defense FY 2018 and FY 2017 Basic Financial Statements DODIG-2019-017.

Nov. 29, 2017

Transmittal of Independent Auditor's Report on the United States Army Corps of Engineers, Civil Works, FY 2017 and FY 2016 Basic Financial Statements DODIG-2018-022

The report begins on page 86 of the Fiscal Year 2017 United States Army Annual Financial Report.

Nov. 20, 2017

Top DoD Management Challenges - Fiscal Year 2018

The following is the DoD Office of Inspector General’s (OIG) statement on the top management and performance challenges facing the DoD. The challenges outlined in this statement were identified based on a variety of factors, including DoD OIG oversight work, research, and judgment; oversight work done by other DoD components; oversight projects conducted by the GAO; and input from DoD officials. While we also reviewed DoD statements, documents, and assessments of these and other critical issues, we identified these top challenges independently.

Nov. 20, 2017

Lead Inspector General for Operation Freedom's Sentinel | Quarterly Report to the United States Congress | July 1, 2017 – September 30, 2017

This Lead Inspector General (Lead IG) report to the United States Congress on Operation Freedom’s Sentinel is the 10th quarterly report detailing the overseas contingency operation (OCO). The report summarizes significant events involving OFS and describes completed, ongoing, and planned Lead IG and oversight partner agency work. This report covers the period from July 1, 2017, to September 30, 2017.

Nov. 20, 2017

Defense Health Agency Controls Over High-Risk Pharmaceutical Payments DODIG-2018-033

We determined whether the Defense Health Agency (DHA) developed controls to identify health care pharmaceutical payments at high risk of fraud or abuse. We focused on controls to prevent and detect potentially fraudulent or abusive claims for pharmaceuticals. The DHA defines “abuse” as any practice that is inconsistent with accepted practice which results in a claim, unnecessary costs, or payment for services or supplies not medically necessary and appropriate, or that fail to meet professionally recognized standards for health care providers. “ Abuse” includes deception or misrepresentation by a provider in relation to a TRICARE claim. We also reviewed the process for approving and implementing new controls.

  • Office of Inspector General, United States Department of Defense, 4800 Mark Center Drive, Alexandria, VA 22350-1500